Study flags novel PRRSV-2 recombinant linked to MLV-like strains

A new paper in Animals reports the emergence of a novel porcine reproductive and respiratory syndrome virus 2 strain in China that was recombined from two modified live virus-like strains and was pathogenic in piglets, underscoring a familiar but still unsettled problem in PRRS control: live vaccine viruses can contribute genetic material to new field-detected variants. While recombination between PRRSV field strains is well established, reports involving vaccine-like strains draw particular attention because they raise practical questions about surveillance, vaccine strategy, and how veterinarians interpret positive molecular results on farms. (mdpi.com)

The background here matters. PRRSV-2 has a long record of mutation and recombination, and NADC30-like lineage 1 viruses have become especially important in China because they have repeatedly served as donors in recombinant strains. Prior studies have already documented recombination between NADC30-like viruses and MLV-like strains, including moderately pathogenic and highly pathogenic variants, as well as vaccine-derived recombinants identified in the US and PRRSV-1 vaccine-vaccine recombinants in Europe. More recently, surveillance groups in North America have also highlighted the growing importance of lineage 1C.5 strains and the value of close genomic monitoring as new clades expand. (pubmed.ncbi.nlm.nih.gov)

Although the full Animals paper was not directly accessible in search results, the study’s abstract states that the authors identified a rare recombination pattern: a novel NADC30-like PRRSV strain derived from two MLV-like strains, then assessed its pathogenicity in piglets. That framing is consistent with a broader literature showing that modified live PRRS vaccines can reduce disease but do not eliminate the evolutionary risk posed by replication-competent vaccine viruses in complex field settings. Reviews of commercial PRRS MLVs have noted recurring concerns around shedding, reversion to virulence, recombination, and uneven cross-protection against heterologous strains. (mdpi.com)

Related work helps put the new report in context. A 2018 study in Viruses described SCN17, a novel PRRSV-2 isolate in China that likely arose through multiple recombination events among NADC30-like, JXA1-like, and RespPRRS MLV-like strains and was moderately pathogenic in piglets. A separate US report described a field strain derived from two PRRSV-2 MLV vaccines in Indiana, showing that vaccine-vaccine recombination is not limited to one geography. And a 2019 French study found a PRRSV-1 field recombinant derived from two commercial MLVs with increased viremia and transmission in SPF pigs. Taken together, those reports suggest the new Animals paper fits into a growing body of evidence that vaccine-like recombinants are uncommon, but credible and epidemiologically relevant. (mdpi.com)

Industry and diagnostic commentary points in the same direction. Swine Health Information Center updates have emphasized that ongoing monitoring of PRRSV genetic diversity is essential as emergent lineages expand. Diagnostic experts cited by The Pig Site have also noted that vaccine-like PRRSV can replicate for extended periods, transmit to unvaccinated pigs, accumulate mutations, and recombine with wild-type virus, which is one reason distinguishing vaccine-related detections from field strains remains challenging. In practical terms, that means a simple ORF5 result may not be enough when clinical signs, vaccine history, and production losses do not line up cleanly. (swinehealth.org)

Why it matters: For veterinary professionals, especially those advising commercial swine systems, the study reinforces three points. First, MLV vaccination remains an important PRRS tool, but it operates within a virus ecosystem that is genetically unstable. Second, unusual outbreak patterns after vaccination may justify deeper sequencing rather than assuming routine vaccine detection or classic field-virus circulation. Third, herd plans should treat vaccination, biosecurity, gilt acclimation, and genomic surveillance as linked decisions, not separate ones. Recent field work has also shown that MLV performance can vary substantially when nursery pigs face multiple heterologous PRRSV strains, which adds another layer to vaccine program design. (mdpi.com)

The broader implication is not that MLV vaccines should be abandoned, but that their use requires disciplined surveillance and interpretation. PRRS remains one of the most economically significant diseases in swine production, and the virus’s capacity for recombination means veterinarians may increasingly need whole-genome data, not just partial typing, to explain herd breaks, vaccine failures, or unexpected severity. That is particularly relevant as lineage 1 viruses continue to diversify and as recombinant strains with different virulence profiles keep appearing in the literature. (swinehealth.org)

What to watch: The next step is whether independent surveillance groups detect similar two-MLV-like recombinants in other herds, whether the authors’ strain proves clinically important outside an experimental setting, and whether regulators, vaccine manufacturers, or herd veterinarians respond by leaning harder on whole-genome sequencing and more conservative vaccine coordination in multi-strain environments. (swinehealth.org)